162 related articles for article (PubMed ID: 32831016)
1. Features of alternative splicing in stomach adenocarcinoma and their clinical implication: a research based on massive sequencing data.
Zhang Y; Ma S; Niu Q; Han Y; Liu X; Jiang J; Chen S; Lin H
BMC Genomics; 2020 Aug; 21(1):580. PubMed ID: 32831016
[TBL] [Abstract][Full Text] [Related]
2. Survival-associated alternative splicing events interact with the immune microenvironment in stomach adenocarcinoma.
Ye ZS; Zheng M; Liu QY; Zeng Y; Wei SH; Wang Y; Lin ZT; Shu C; Zheng QH; Chen LC
World J Gastroenterol; 2021 Jun; 27(21):2871-2894. PubMed ID: 34135559
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome-wide analysis of alternative mRNA splicing signature in the diagnosis and prognosis of stomach adenocarcinoma.
Shi Y; Chen Z; Gao J; Wu S; Gao H; Feng G
Oncol Rep; 2018 Oct; 40(4):2014-2022. PubMed ID: 30106437
[TBL] [Abstract][Full Text] [Related]
4. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
[TBL] [Abstract][Full Text] [Related]
5. Survival-Associated Alternative Messenger RNA Splicing Signatures in Pancreatic Ductal Adenocarcinoma: A Study Based on RNA-Sequencing Data.
Zhou YJ; Zhu GQ; Zhang QW; Zheng KI; Chen JN; Zhang XT; Wang QW; Li XB
DNA Cell Biol; 2019 Nov; 38(11):1207-1222. PubMed ID: 31483163
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel prognostic alternative splicing signature in papillary renal cell carcinoma.
Duan Y; Zhang D
J Cell Biochem; 2020 Jan; 121(1):672-689. PubMed ID: 31407370
[TBL] [Abstract][Full Text] [Related]
7. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
[TBL] [Abstract][Full Text] [Related]
9. Systematic profiling of a novel prognostic alternative splicing signature in hepatocellular carcinoma.
Zhang D; Duan Y; Wang Z; Lin J
Oncol Rep; 2019 Dec; 42(6):2450-2472. PubMed ID: 31578577
[TBL] [Abstract][Full Text] [Related]
10. Prognostic index of aberrant mRNA splicing profiling acts as a predictive indicator for hepatocellular carcinoma based on TCGA SpliceSeq data.
Wu HY; Peng ZG; He RQ; Luo B; Ma J; Hu XH; Dang YW; Chen G; Pan SL
Int J Oncol; 2019 Aug; 55(2):425-438. PubMed ID: 31268164
[TBL] [Abstract][Full Text] [Related]
11. Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma.
Gu J; Li Y; Fan L; Zhao Q; Tan B; Hua K; Wu G
Oncotarget; 2017 Jul; 8(30):49201-49216. PubMed ID: 28484081
[TBL] [Abstract][Full Text] [Related]
12. Systematic Analysis of Survival-Associated Alternative Splicing Signatures in Gastrointestinal Pan-Adenocarcinomas.
Lin P; He RQ; Ma FC; Liang L; He Y; Yang H; Dang YW; Chen G
EBioMedicine; 2018 Aug; 34():46-60. PubMed ID: 30131306
[TBL] [Abstract][Full Text] [Related]
13. The Role of Alternative Splicing Factors, DDB2-Related Ageing and DNA Damage Repair in the Progression and Prognosis of Stomach Adenocarcinoma Patients.
Wang X; Huang Z; Li L; Yang Y; Zhang J; Wang L; Yuan J; Li Y
Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672781
[TBL] [Abstract][Full Text] [Related]
14. A novel microRNA signature predicts survival in stomach adenocarcinoma.
Ding B; Gao X; Li H; Liu L; Hao X
Oncotarget; 2017 Apr; 8(17):28144-28153. PubMed ID: 28423653
[TBL] [Abstract][Full Text] [Related]
15. Exploration of predictive and prognostic alternative splicing signatures in lung adenocarcinoma using machine learning methods.
Cai Q; He B; Zhang P; Zhao Z; Peng X; Zhang Y; Xie H; Wang X
J Transl Med; 2020 Dec; 18(1):463. PubMed ID: 33287830
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of an immune-related gene prognostic model for stomach adenocarcinoma.
Wu M; Xia Y; Wang Y; Fan F; Li X; Song J; Ding J
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33112406
[TBL] [Abstract][Full Text] [Related]
17. A novel alternative splicing-based prediction model for uteri corpus endometrial carcinoma.
Gao L; Xie ZC; Pang JS; Li TT; Chen G
Aging (Albany NY); 2019 Jan; 11(1):263-283. PubMed ID: 30640723
[TBL] [Abstract][Full Text] [Related]
18. Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma.
Zhang S; Wu X; Diao P; Wang C; Wang D; Li S; Wang Y; Cheng J
J Cell Physiol; 2020 May; 235(5):4804-4813. PubMed ID: 31637730
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value and Potential Regulatory Mechanism of Alternative Splicing in Geriatric Breast Cancer.
Li X; Wang Y; Li B; Ma W
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32079071
[TBL] [Abstract][Full Text] [Related]
20. Survival-associated alternative splicing signatures in non-small cell lung cancer.
Zhao D; Zhang C; Jiang M; Wang Y; Liang Y; Wang L; Qin K; Rehman FU; Zhang X
Aging (Albany NY); 2020 Apr; 12(7):5878-5893. PubMed ID: 32282333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]